| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |